Patrick C. May

9.9k total citations · 1 hit paper
92 papers, 6.6k citations indexed

About

Patrick C. May is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Patrick C. May has authored 92 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Physiology, 34 papers in Molecular Biology and 26 papers in Pharmacology. Recurrent topics in Patrick C. May's work include Alzheimer's disease research and treatments (59 papers), Cholinesterase and Neurodegenerative Diseases (25 papers) and Computational Drug Discovery Methods (23 papers). Patrick C. May is often cited by papers focused on Alzheimer's disease research and treatments (59 papers), Cholinesterase and Neurodegenerative Diseases (25 papers) and Computational Drug Discovery Methods (23 papers). Patrick C. May collaborates with scholars based in United States, United Kingdom and Singapore. Patrick C. May's co-authors include David M. Holtzman, Kelly R. Bales, Caleb E. Finch, John R. Cirrito, Steven M. Paul, Ronald B. DeMattos, Eric Siemers, Kimberly S. Fuson, Judes Poirier and Darryle D. Schoepp and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Patrick C. May

92 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo

2005 1.0k citations John R. Cirrito, Kelvin A. Yamada et al. Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick C. May United States	33	4.6k	2.4k	1.5k	1.5k	999	92	6.6k
Jan Näslund Sweden	30	5.4k 1.2×	3.4k 1.4×	1.0k 0.7×	1.4k 0.9×	1.0k 1.0×	51	7.0k
M. Paul Murphy United States	43	5.8k 1.3×	3.4k 1.4×	2.1k 1.4×	1.4k 0.9×	732 0.7×	75	8.9k
Chris Eckman United States	11	6.7k 1.5×	3.0k 1.2×	2.2k 1.5×	1.8k 1.2×	1.2k 1.2×	13	8.0k
Lisa McConlogue United States	31	6.0k 1.3×	3.6k 1.5×	2.2k 1.5×	1.7k 1.2×	1.1k 1.1×	41	8.2k
Oliver Wirths Germany	46	4.9k 1.1×	2.3k 1.0×	1.9k 1.3×	1.1k 0.8×	809 0.8×	120	6.7k
Takeshi Kawarabayashi Japan	31	4.1k 0.9×	2.2k 0.9×	1.3k 0.9×	889 0.6×	534 0.5×	129	5.7k
Mary Jo LaDu United States	51	7.1k 1.6×	3.8k 1.6×	2.0k 1.3×	1.3k 0.9×	962 1.0×	105	9.6k
Dennis J. Selkoe United States	15	4.8k 1.1×	3.2k 1.3×	1.2k 0.8×	1.3k 0.9×	898 0.9×	17	6.4k
Ronald B. DeMattos United States	39	6.8k 1.5×	3.1k 1.3×	1.3k 0.9×	1.7k 1.2×	1.4k 1.4×	71	9.4k
Marcia B. Podlisny United States	30	5.4k 1.2×	3.2k 1.3×	1.1k 0.7×	1.3k 0.9×	837 0.8×	38	6.2k

Countries citing papers authored by Patrick C. May

Since Specialization

Citations

This map shows the geographic impact of Patrick C. May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. May more than expected).

Fields of papers citing papers by Patrick C. May

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick C. May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. May. The network helps show where Patrick C. May may publish in the future.

Co-authorship network of co-authors of Patrick C. May

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick C. May. A scholar is included among the top collaborators of Patrick C. May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick C. May. Patrick C. May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cummings, Jeffrey L., María Isabel González, Martyn C. Pritchard, et al.. (2023). The therapeutic landscape of tauopathies: challenges and prospects. Alzheimer s Research & Therapy. 15(1). 168–168. 31 indexed citations

Hölttä, Mikko, Robert A. Dean, Eric Siemers, et al.. (2016). A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans. Alzheimer s Research & Therapy. 8(1). 11–11. 19 indexed citations

Portelius, Erik, Robert A. Dean, Ulf Andréasson, et al.. (2014). β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage. Alzheimer s Research & Therapy. 6(5-8). 75–75. 29 indexed citations

Siemers, Eric, Robert A. Dean, Stuart Friedrich, et al.. (2007). Safety, Tolerability, and Effects on Plasma and Cerebrospinal Fluid Amyloid-β After Inhibition of γ-Secretase. Clinical Neuropharmacology. 30(6). 317–325. 121 indexed citations

Siemers, Eric, Robert A. Dean, Ronald B. DeMattos, & Patrick C. May. (2006). New pathways in drug discovery for alzheimer’s disease. Current Neurology and Neuroscience Reports. 6(5). 372–378. 10 indexed citations

Cirrito, John R., Kelvin A. Yamada, Mary Beth Finn, et al.. (2005). Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo. Neuron. 48(6). 913–922. 1003 indexed citations breakdown →

Yu, Liang, Suizhen Lin, Thomas P. Beyer, et al.. (2004). A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. Journal of Neurochemistry. 88(3). 623–634. 135 indexed citations

Yang, Hsiu‐Chiung, Xiyun Chai, Marian Mosior, et al.. (2004). Biochemical and kinetic characterization of BACE1: investigation into the putative species‐specificity for β‐ and β′‐cleavage sites by human and murine BACE1. Journal of Neurochemistry. 91(6). 1249–1259. 11 indexed citations

Searfoss, George H., William H. Jordan, David O. Calligaro, et al.. (2003). Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional γ-Secretase Inhibitor. Journal of Biological Chemistry. 278(46). 46107–46116. 258 indexed citations

10.

Chen, Shuhui, Todd J. Kohn, Hsiu‐Chiung Yang, et al.. (2003). P3 cap modified Phe*-Ala series BACE inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 245–250. 17 indexed citations

11.

Hu, Jingdan, Ana B. Bueno, Hsiu‐Chiung Yang, et al.. (2003). Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR. Bioorganic & Medicinal Chemistry Letters. 14(1). 239–243. 26 indexed citations

12.

Liu, Feng, Su Yuan, Baolin Li, et al.. (2003). Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5. FEBS Letters. 547(1-3). 193–196. 86 indexed citations

13.

May, Patrick C., et al.. (1999). Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonists against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures. Neuroscience Letters. 262(3). 219–221. 16 indexed citations

14.

Mark, Robert J., et al.. (1999). Fibroblast growth factor-8 protects cultured rat hippocampal neurons from oxidative insult. Brain Research. 830(1). 88–93. 22 indexed citations

15.

Boggs, Leonard N., Kimberly S. Fuson, Melvyn Baez, et al.. (1996). Clusterin (Apo J) Protects Against In Vitro Amyloid‐β(1–40) Neurotoxicity. Journal of Neurochemistry. 67(3). 1324–1327. 92 indexed citations

16.

Stephenson, Diane, Joseph Manetta, D. L. White, et al.. (1994). Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes. Brain Research. 637(1-2). 97–105. 76 indexed citations

17.

May, Patrick C.. (1993). Sulfated Glycoprotein‐2: An Emerging Molecular Marker for Neurodegeneration. Annals of the New York Academy of Sciences. 679(1). 235–244. 17 indexed citations

18.

May, Patrick C., Leonard N. Boggs, & Kimberly S. Fuson. (1993). Neurotoxicity of Human Amylin in Rat Primary Hippocampal Cultures: Similarity to Alzheimer's Disease Amyloid‐β Neurotoxicity. Journal of Neurochemistry. 61(6). 2330–2333. 109 indexed citations

19.

Poirier, Judes, Mark A. Hess, Patrick C. May, & Caleb E. Finch. (1991). Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Molecular Brain Research. 11(2). 97–106. 327 indexed citations

20.

Nichols, Nancy R., et al.. (1988). Rapid Corticosterone-lnduced Changes in Gene Expression in Rat Hippocampus Display Type II Glucocorticoid Receptor Specificity. Molecular Endocrinology. 2(3). 284–290. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact